All sponsors

Krystal Biotech, Inc. $KRYS

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-31
RECRUITING4
READOUTS ≤12 MONTHS4
Open Krystal Biotech, Inc. on the live radar map → 📅 $KRYS readout calendar (.ics)
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Pearl-2
NCT06724900
P1/2Active, not recruitingWrinkles in Decolletage; Pigmentation192025-07
IOLITE
NCT07016750
P3RecruitingDystrophic Epidermolysis Bullosa; DEB - Dystrophic Epidermolysis Bullosa162026-12 (+9 mo)
EMERALD-1
NCT06999733
P1/2RecruitingNeurotrophic Keratitis602026-12 (+12 mo)
KYANITE-1
NCT06228326
P1/2RecruitingLung Cancer, Non-small Cell; Lung Cancer Metastatic2502027-02
KB707
NCT05970497
P1/2RecruitingCancer; Melanoma Stage III2402027-07 (+12 mo)